Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral fingolimod in relapsing-remitting multiple sclerosis
IRCT201406018323N10Phase 4Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fingolimod in multiple sclerosis (MS), sponsored by Kermanshah University of Medical Sciences. Started Dec 2014; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT201406018323N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201406018323N10.